Simulated Diabetes Training for Resident Physicians

Not Applicable

Completed

• Conditions: Type 2 Diabetes
• Interventions: Other: Early SimCare Diabetes Group; Other: Delayed SimCare Diabetes Group

• Registration Number: NCT00979823
• Lead Sponsor: HealthPartners Institute

Brief Summary

The objective of this translational research is to study the effect of implementing an innovative simulated diabetes learning intervention within primary care residency programs. The intervention uses cognitive behavioral learning theory to provide goal-directed feedback to residents after every encounter over a series of virtual patient-physician encounters. Formulas derived from pharmacokinetic data and the experience of clinical experts model simulated physiologic responses to drug changes, health behaviors, and adherence factors. The online intervention is economical, sustainable, and addresses a number of current obstacles to outpatient diabetes training in primary care residency programs.

In this group trial, we randomly assign about 20 primary care residency programs with up to 700 residents total to either an (a) Early learning program group or (b) Delayed learning program group. We will assess the ability of residents to achieve evidence-based diabetes clinical goals and avoid potential medical safety issues for glycemia, blood pressure, and lipids on simulated assessment cases. Secondary analyses will evaluate the actual use of the tool by residents, direct costs of the program, and resident satisfaction.

Detailed Description

Specific aim 1: To examine the impact of a simulated case-based learning intervention on measures of quality of diabetes care delivered by primary care residents to simulated adult patients with diabetes mellitus.

Hypothesis 1: Compared to delayed SimCare Diabetes learning program group residents, those residents in the early SimCare Diabetes learning program group will treat a higher proportion of simulated patients to evidence based diabetes goals including glycemic control (A1c \< 7%), blood pressure control (BP \< 130/80 mm Hg), and lipid control (evidence-based LDL, Triglyceride, and HDL levels).

Specific aim 2: To examine the impact of a simulated case-based learning intervention on rates of appropriate drug intensification and number of risky prescribing events in the management of simulated adult patients with diabetes mellitus.

Hypothesis 2: Compared to delayed SimCare Diabetes learning program group residents, those residents in the early SimCare Diabetes learning program group will have improved rates of appropriate drug intensification in simulated assessment cases.

Hypothesis 3: Compared to delayed SimCare Diabetes learning program group residents, those residents in the early SimCare Diabetes learning program group will have a lower number of risky prescribing events in simulated assessment cases.

Study Timeline

• Study First Submitted: 2009-09-16
• Study First Submitted QC: 2009-09-17
• Study First Posted: 2009-09-18
• Study Start: 2010-09
• Primary Completion: 2012-07
• Study Completion: 2013-07
• Status Verified: 2014-12
• Last Update Submitted: 2014-12-01
• Last Update Posted: 2014-12-03

Recruitment & Eligibility

• Status: COMPLETED
• Sex: All
• Target Recruitment: 341

Inclusion Criteria

Not provided

Exclusion Criteria

Not provided

Study & Design

• Study Type: INTERVENTIONAL
• Study Design: PARALLEL

Arm && Interventions

Group	Intervention	Description
Early SimCare Diabetes Group	Early SimCare Diabetes Group	This group will receive an email web-link to 3 simulated learning cases each month for 6 months. After 6 months (18 total learning cases), they will then complete 4 simulated assessment cases, a diabetes knowledge survey, and a satisfaction survey.
Delayed SimCare Diabetes Group	Delayed SimCare Diabetes Group	Beginning in the spring of 2011, residents in this group will receive an email web-link to complete 4 simulated assessment cases and a diabetes knowledge survey. They will subsequently be sent 3 learning cases a month for 6 months and a satisfaction survey to complete.

Primary Outcome Measures

Name	Time	Method
Drug intensification	September 2010 - July 2013
Treatment according to evidence-based diabetes goals	September 2010 - July 2013
Number of risky prescribing events	September 2010 - July 2013

Secondary Outcome Measures

Name	Time	Method
Secondary analyses will evaluate the actual use of the tool by residents, direct costs of the program, and resident satisfaction.	July 2011 - January 2013

Trial Locations

Locations (1)

HealthPartners Research Foundation; 🇺🇸 Minneapolis, Minnesota, United States